COVID-19大流行对慢性疼痛的影响:一项叙述性综述
本叙述性综述探讨COVID-19大流行对慢性疼痛的影响,检索涉及大流行对慢性疼痛负担、长COVID新发疼痛机制、疫苗与疼痛干预的文献。综述指出SARS-CoV-2感染通过系统性炎症免疫、直接神经病理或继发性机制引起疼痛,感染增加疼痛和头痛患者绝对数,新发慢性疼痛常见但患病率随时间下降且症状波动,需推进多学科机制导向治疗研究。
要点
- SARS-CoV-2感染增加疼痛和头痛患者绝对数,新发慢性疼痛常见但患病率随时间下降。
- 长COVID疼痛机制包括系统性炎症免疫、直接神经病理和继发性机制。
- 部分证据提示类固醇暴露可能影响疫苗效力,但尚无临床后果证据。
核心结论
- COVID-19大流行对慢性疼痛患者影响不一,健康社会决定因素似乎影响影响程度。
- SARS-CoV-2感染增加疼痛和头痛的绝对患者数,新发慢性疼痛常见且可能涉及多种机制。
- 需推进多学科护理领域内基于机制的治疗研究。
研究设计与样本
- 叙述性综述,检索与COVID-19大流行影响慢性疼痛负担、长COVID新发疼痛机制、COVID-19疫苗和疼痛干预相关的出版物。
主要发现
- SARS-CoV-2感染增加疼痛和头痛的绝对患者数。
- 急性期头痛作为首发症状预示较轻病程。
- 新发慢性疼痛据报道常见,可能涉及多种机制,但患病率随时间下降且症状波动。
- 需要强化支持的患者尤其易感长COVID症状。
- 部分证据提示类固醇暴露可能影响疫苗效力,但至今无临床后果证据。
临床怎么用
- 现有慢性疼痛管理可能有助于症状缓解。
- 需在多学科护理领域推进基于机制的治疗研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The COVID-19 pandemic transformed everyday life, but the implications were most impactful for vulnerable populations, including patients with chronic pain. Moreover, persistent pain is increasingly recognised as a key manifestation of long COVID. This narrative review explores the consequences of the COVID-19 pandemic for chronic pain. Publications were identified related to the COVID-19 pandemic influence on the burden of chronic pain, development of new-onset pain because of long COVID with proposed mechanisms and COVID-19 vaccines and pain interventions. Broadly, mechanisms underlying pain due to SARS-CoV-2 infection could be caused by 'systemic inflammatory-immune mechanisms', 'direct neuropathic mechanisms' or 'secondary mechanisms due to the viral infection or treatment'. Existing chronic pain populations were variably impacted and social determinants of health appeared to influence the degree of effect. SARS-CoV-2 infection increased the absolute numbers of patients with pain and headache. In the acute phase, headache as a presenting symptom predicted a milder course. New-onset chronic pain was reportedly common and likely involves multiple mechanisms; however, its prevalence decreases over time and symptoms appear to fluctuate. Patients requiring intensive support were particularly susceptible to long COVID symptoms. Some evidence suggests steroid exposure (often used for pain interventions) may affect vaccine efficacy, but there is no evidence of clinical repercussions to date. Although existing chronic pain management could help with symptomatic relief, there is a need to advance research focusing on mechanism-based treatments within the domain of multidisciplinary care.
引用
- Shanthanna H, Nelson AM, Kissoon N, et al. The COVID-19 pandemic and its consequences for chronic pain: a narrative review. Anaesthesia. 2022. PMID: 35848380. doi:10.1111/anae.15801
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。